Intestinal and Extra-Intestinal Manifestations of Campylobacter in the Immunocompromised Host

Alexandros G.Sfakianakis shared this article with you from Inoreader Intestinal and Extra-Intestinal Manifestations of Campylobacter in the Immunocompromised Host Μέσω Current Treatment Options in Infectious Diseases Abstract Purpose of review Describe most recent data on manifestations and treatment of intestinal and extra-intestinal manifestations of Campylobacter among immunocompromised patients. Recent findings Resistance to fluoroquinolones, macrolides, and tetracycline challenge traditional empiric therapies. Summary Recurrent Campylobacter enteritis and bacteremia are associated with hypogammaglobinemia, HIV, transplant-associated immunotherapy, and hematologic malignancies. C. jejuni and C. coli are the most commonly associated Campylobacter species although C. fetus, C. upsaliensis, C. lari, C. curvus, and C. rectus should be considered as potential causative agents of rare extra-intestinal infections. Successful diagnosis and treatment of these cases may require the recognition of the limits of standard diagnostics and the recent emergence of highly resistant strains of Campylobacter, particularly C. coli. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.